Paul D Loprinzi1, Jeremy P Loenneke. 1. Dept of Health, Exercise Science, and Recreation Management, University of Mississippi, University, MS.
Abstract
OBJECTIVE: Leukocyte telomere length (LTL) shortening is characteristic of aging and is associated with morbidity and mortality, independent of age. Research demonstrates that lower extremity muscular strength is associated with mobility, morbidity and mortality; however, no study, to our knowledge, had examined the association between lower extremity muscular strength and LTL, which was the purpose of this brief study. METHODS: Data from the 1999-2002 NHANES was used (N = 2410; 50-85 years). Peak isokinetic knee extensor strength (IKES) was objectively measured with LTL assessed from a blood sample. RESULTS: After adjustments, for every 50 N increase in IKES, participants had a 9% reduced odds (P = .04) of being in the 1st (vs. 4th) LTL quartile. DISCUSSION: Lower extremity muscular strength is associated with LTL, suggesting a possible mechanism through which lower extremity muscular strength may be associated with morbidity and mortality.
OBJECTIVE: Leukocyte telomere length (LTL) shortening is characteristic of aging and is associated with morbidity and mortality, independent of age. Research demonstrates that lower extremity muscular strength is associated with mobility, morbidity and mortality; however, no study, to our knowledge, had examined the association between lower extremity muscular strength and LTL, which was the purpose of this brief study. METHODS: Data from the 1999-2002 NHANES was used (N = 2410; 50-85 years). Peak isokinetic knee extensor strength (IKES) was objectively measured with LTL assessed from a blood sample. RESULTS: After adjustments, for every 50 N increase in IKES, participants had a 9% reduced odds (P = .04) of being in the 1st (vs. 4th) LTL quartile. DISCUSSION: Lower extremity muscular strength is associated with LTL, suggesting a possible mechanism through which lower extremity muscular strength may be associated with morbidity and mortality.
Authors: James Steele; Andrew Butler; Zoe Comerford; Jason Dyer; Nathan Lloyd; Joshua Ward; James Fisher; Paulo Gentil; Christopher Scott; Hayao Ozaki Journal: PeerJ Date: 2018-02-28 Impact factor: 2.984
Authors: James Steele; James Fisher; Martin Skivington; Chris Dunn; Josh Arnold; Garry Tew; Alan M Batterham; David Nunan; Jamie M O'Driscoll; Steven Mann; Chris Beedie; Simon Jobson; Dave Smith; Andrew Vigotsky; Stuart Phillips; Paul Estabrooks; Richard Winett Journal: BMC Public Health Date: 2017-04-05 Impact factor: 3.295
Authors: Dylan M Williams; Jessica L Buxton; Marko T Kantomaa; Tuija H Tammelin; Alexandra I F Blakemore; Marjo-Riitta Järvelin Journal: Am J Epidemiol Date: 2017-04-01 Impact factor: 4.897
Authors: Diego Montiel Rojas; Andreas Nilsson; Elodie Ponsot; Robert J Brummer; Susan Fairweather-Tait; Amy Jennings; Lisette C P G M de Groot; Agnes Berendsen; Barbara Pietruszka; Dawid Madej; Elodie Caumon; Nathalie Meunier; Corinne Malpuech-Brugère; Giulia Guidarelli; Aurelia Santoro; Claudio Franceschi; Fawzi Kadi Journal: Front Physiol Date: 2018-08-10 Impact factor: 4.566